Search results for "Etoricoxib"

showing 4 items of 4 documents

Novel Insights and Therapeutical Applications in the Field of Inhibitors of COX-2

2004

The discovery of the two isoenzymes COX-1 and COX-2 and the knowledge of their function, localisation and regulation has initiated the development of COX-2 selective inhibitors (coxibs). Inducible COX-2 at the peripheral site of inflammation has been detected in the early 1990s, the involvement of recently detected spinal COX-2 has led to new insights into mechanisms of pain and may explain analgesic and antipyretic properties of COX-2 selective inhibitors. The coxibs rofecoxib and celecoxib have been introduced into therapy and seem to offer some advantages over the classical non-selective NSAIDs. The search for new COX-2 inhibitors is going on, the development of etoricoxib and lumiracox…

AnalgesicArthritisPharmacologyBioinformaticsBiochemistryProstate cancerDrug DiscoverymedicineAnimalsHumansCyclooxygenase InhibitorsRofecoxibPharmacologyCyclooxygenase 2 Inhibitorsbusiness.industryOrganic ChemistryMembrane Proteinsmedicine.diseaseTolerabilityCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesCelecoxibMolecular MedicineLumiracoxibbusinessEtoricoxibmedicine.drugCurrent Medicinal Chemistry
researchProduct

Effect of preemptive dexamethasone and etoricoxib on postoperative period following impacted third molar surgery - a randomized clinical trial.

2019

Background The aim of this study was to compare the anti-inflammatory effects of dexamethasone and etoricoxib after third molar extraction. Material and Methods A prospective, randomized, controlled, split-mouth study was conducted. 19 volunteers were allocated randomly to receive 90mg etoricoxib 1 hour prior to the procedure or 4mg intramuscular dexamethasone immediately after anesthesia. Baseline measurements were obtained preoperatively, and subsequent assessments were made on immediate postoperative, at 72 hours and 7 days after surgery to measure postoperative facial swelling by use of linear measurements, interincisal mouth opening width and visual analog scale score for pain. The amo…

Molarmedicine.drug_classAnti-Inflammatory AgentsTrismusDexamethasonelaw.invention03 medical and health sciencesEtoricoxib0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawStatistical significanceMedicineEdemaHumansProspective StudiesProspective cohort studyGeneral DentistryDexamethasonePain MeasurementPain Postoperativebusiness.industryResearchTooth Impacted030206 dentistry:CIENCIAS MÉDICAS [UNESCO]OtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASTooth ExtractionCorticosteroidSurgeryMolar ThirdTrismusmedicine.symptomOral SurgerybusinessEtoricoxibmedicine.drugMedicina oral, patologia oral y cirugia bucal
researchProduct

RT-qPCR study of COX-1 and -2 genes in oral surgical model comparing single-dose preemptive ibuprofen and etoricoxib: A randomized clinical trialy

2019

Background This study aimed to evaluate the gene expression of cyclooxygenases (COXs) in an oral model of preemptive analgesia. Material and Methods Gingival tissue was collected during extraction of lower third molars from a randomized, triple-blind, split-mouth and placebo-controlled study. The eligible patients were randomly sorted to receive a single dose either of ibuprofen 400mg, or etoricoxib 120 mg or a placebo, one hour prior to surgery. The temporal course of RNAm was evaluated for COX-1 and -2 by means of a quantitative polymerase chain reaction in real time (RT-qPCR) at time zero and 30 minutes after the surgical procedure began, and it was correlated with clinical parameters (p…

Molarmedicine.medical_specialtyTime zerobusiness.industryResearchmedicine.medical_treatment030206 dentistry:CIENCIAS MÉDICAS [UNESCO]PlaceboIbuprofenGastroenterology03 medical and health sciences0302 clinical medicineReal-time polymerase chain reactionDental extraction030220 oncology & carcinogenesisInternal medicineUNESCO::CIENCIAS MÉDICASmedicineOral SurgerybusinessGeneral DentistryEtoricoxibTissue inflammationmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Seizure following the Use of the COX-2 Inhibitor Etoricoxib

2017

We describe a case of epileptic seizures occurring after the use of a COX-2 inhibitor. A 61-year-old man was admitted to our department because of a generalized tonic-clonic seizure. EEG showed generalized slowdown of the activity. Neuroimaging and blood samples studies did not evidence alterations, but a careful pharmacological history revealed that the patient had taken the COX-2 inhibitor etoricoxib to treat lumbago few days before the onset of clinical symptoms. No seizures were reported after etoricoxib discontinuation and an EEG resulted to be normal two months after this. Conclusion. Knowing the pharmacological history of a patient is important for understanding the clinical presenta…

medicine.diagnostic_testbusiness.industryCase Report030204 cardiovascular system & hematologyElectroencephalographylcsh:RC346-429Discontinuation03 medical and health sciences0302 clinical medicineText miningNeuroimagingAnesthesiaMedicineCOX-2 inhibitorCOX-2 inhibitorGeneral Agricultural and Biological SciencesbusinessEtoricoxib030217 neurology & neurosurgerylcsh:Neurology. Diseases of the nervous systemmedicine.drugCase Reports in Neurological Medicine
researchProduct